Mesangial C3 deposition and serum C3 levels predict renal outcome in IgA nephropathy. 2021

Dan Wu, and Xueqian Li, and Xingfeng Yao, and Nan Zhang, and Lei Lei, and Hejia Zhang, and Mengmeng Tang, and Jie Ni, and Chen Ling, and Zhi Chen, and Xiangmei Chen, and Xiaorong Liu
Department of Nephrology, Beijing Children's Hospital, Capital Medical University, Beijing, 100045, China.

BACKGROUND Complement activation plays an important role in the pathogenesis of IgA nephropathy (IgAN). We aimed to evaluate the relationship between mesangial C3 deposition and histologic lesions and to investigate the role of mesangial C3 deposition and serum C3 reduction in predicting renal outcome in IgAN children. METHODS We performed a retrospective cohort study in children with biopsy-proven IgAN. Mesangial C3 deposition (< 2+ vs. ≥ 2+) was detected by the immunofluorescence. Histopathologic kidney grades were determined by the Oxford classification. A decreased serum C3 concentration (hypoC3) was defined when C3 < 90 mg/dl. The endpoint was composite kidney outcome with either a 30% decline in glomerular filtration rates from baseline or kidney failure during the follow-up period. RESULTS A total of 98 children were analyzed. Mesangial hypercellularity (M) was an independent factor associated with mesangial C3 deposition (HR 3.267; 95% CI 1.028-10.389; P = 0.045). After a median follow-up period of 25 months (interquartile range 18-36 months), 6 (6.1%) children reached the endpoint. Compared with other children, a significantly higher proportion of children with composite kidney outcomes had mesangial C3 deposition ≥ 2+ and hypoC3 (3.4% versus 27.3%, P = 0.002). After adjustment for clinicopathologic risk factors, mesangial C3 deposition ≥ 2+ and hypoC3 were associated with renal outcome (HR 9.772; 95% CI 1.264-75.518; P = 0.029). CONCLUSIONS Mesangial C3 deposition was associated with M in IgAN. Mesangial C3 deposition and hypoC3 were risk factors for renal outcome in children with IgAN.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D005260 Female Females
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D005919 Glomerular Filtration Rate The volume of water filtered out of plasma through glomerular capillary walls into Bowman's capsules per unit of time. It is considered to be equivalent to INULIN clearance. Filtration Rate, Glomerular,Filtration Rates, Glomerular,Glomerular Filtration Rates,Rate, Glomerular Filtration,Rates, Glomerular Filtration

Related Publications

Dan Wu, and Xueqian Li, and Xingfeng Yao, and Nan Zhang, and Lei Lei, and Hejia Zhang, and Mengmeng Tang, and Jie Ni, and Chen Ling, and Zhi Chen, and Xiangmei Chen, and Xiaorong Liu
January 2012, PloS one,
Dan Wu, and Xueqian Li, and Xingfeng Yao, and Nan Zhang, and Lei Lei, and Hejia Zhang, and Mengmeng Tang, and Jie Ni, and Chen Ling, and Zhi Chen, and Xiangmei Chen, and Xiaorong Liu
February 2020, Clinical immunology (Orlando, Fla.),
Dan Wu, and Xueqian Li, and Xingfeng Yao, and Nan Zhang, and Lei Lei, and Hejia Zhang, and Mengmeng Tang, and Jie Ni, and Chen Ling, and Zhi Chen, and Xiangmei Chen, and Xiaorong Liu
February 2018, Pediatrics international : official journal of the Japan Pediatric Society,
Dan Wu, and Xueqian Li, and Xingfeng Yao, and Nan Zhang, and Lei Lei, and Hejia Zhang, and Mengmeng Tang, and Jie Ni, and Chen Ling, and Zhi Chen, and Xiangmei Chen, and Xiaorong Liu
December 2023, Clinical journal of the American Society of Nephrology : CJASN,
Dan Wu, and Xueqian Li, and Xingfeng Yao, and Nan Zhang, and Lei Lei, and Hejia Zhang, and Mengmeng Tang, and Jie Ni, and Chen Ling, and Zhi Chen, and Xiangmei Chen, and Xiaorong Liu
March 2021, Translational pediatrics,
Dan Wu, and Xueqian Li, and Xingfeng Yao, and Nan Zhang, and Lei Lei, and Hejia Zhang, and Mengmeng Tang, and Jie Ni, and Chen Ling, and Zhi Chen, and Xiangmei Chen, and Xiaorong Liu
August 2007, Kidney international,
Dan Wu, and Xueqian Li, and Xingfeng Yao, and Nan Zhang, and Lei Lei, and Hejia Zhang, and Mengmeng Tang, and Jie Ni, and Chen Ling, and Zhi Chen, and Xiangmei Chen, and Xiaorong Liu
November 2021, Clinical and experimental medicine,
Dan Wu, and Xueqian Li, and Xingfeng Yao, and Nan Zhang, and Lei Lei, and Hejia Zhang, and Mengmeng Tang, and Jie Ni, and Chen Ling, and Zhi Chen, and Xiangmei Chen, and Xiaorong Liu
February 2024, Kidney & blood pressure research,
Dan Wu, and Xueqian Li, and Xingfeng Yao, and Nan Zhang, and Lei Lei, and Hejia Zhang, and Mengmeng Tang, and Jie Ni, and Chen Ling, and Zhi Chen, and Xiangmei Chen, and Xiaorong Liu
November 2020, Nutrition, metabolism, and cardiovascular diseases : NMCD,
Dan Wu, and Xueqian Li, and Xingfeng Yao, and Nan Zhang, and Lei Lei, and Hejia Zhang, and Mengmeng Tang, and Jie Ni, and Chen Ling, and Zhi Chen, and Xiangmei Chen, and Xiaorong Liu
June 1991, Acta paediatrica Japonica : Overseas edition,
Copied contents to your clipboard!